FDA MedWatch News

MedWatch Safety Alert RSS Feed


FDA MedWatch Safety Alerts

Succinylcholine Chloride 20mg/mL 5mL Syringe by Fagron Sterile Services: Recall - Potential Lack Of Sterility Assurance

Reasonable probability that patient may experience adverse events ranging from fever, chills and malaise, to severe adverse events including systemic invasive mycoses or systemic bacterial sepsis.

Venture Catheters by Vascular Solutions: Recall - Excess Material May Split or Separate During Use

UPDATED 06/23/2017. All unexpired lots of the RX, OTW, and CS versions are recalled. Material in the patient's bloodstream can result in serious adverse health consequences such as the development of blood clots, embolism of the excess material to vital organs, or death.

Potassium Phosphate and Succinylcholine by Advanced Pharma: Recall - Potential Lack of Sterility Assurance

Patient may experience adverse events ranging from fever, chills and malaise, to severe adverse events including systemic invasive mycoses or systemic bacterial sepsis.

System CS100, CS100i and CS300 Intra-Aortic Balloon Pumps by Datascope: Field Correction - Potential Electrical Test Failure Code

Risk of failure of the device to initiate therapy.

Clindamycin Injection ADD-Vantage Vials by Alvogen: Recall - Lack of Sterility Assurance

There is a reasonable probability that the patient may experience adverse events, ranging from fever, chills and malaise, to severe adverse events including systemic invasive mycoses or systemic bacterial sepsis.






Feed aggregation powered by Syndicate Press.